56 related articles for article (PubMed ID: 9098773)
21. Cardiac surgery in patients with dialysis-dependent renal disease.
Suehiro S; Shibata T; Sasaki Y; Murakami T; Hosono M; Fujii H; Kinoshita H
Ann Thorac Cardiovasc Surg; 1999 Dec; 5(6):376-81. PubMed ID: 10637387
[TBL] [Abstract][Full Text] [Related]
22. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
Roĭtman EV; Dement'eva II; Meshcheriakov AV
Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253
[No Abstract] [Full Text] [Related]
23. Histamine in plasma and bronchoalveolar lavage fluid during cardiac surgery: Comparison of a heparin-coated and a non-coated circuit.
Lin AH; van Overveld FJ; Rodrigus I; Moulijn A; De Backer WA
Inflamm Res; 1997 Mar; 46(Suppl 1):75-6. PubMed ID: 27518011
[No Abstract] [Full Text] [Related]
24. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
[TBL] [Abstract][Full Text] [Related]
25. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass.
Muriithi EW; Belcher PR; Rao JN; Chaudhry MA; Nicol D; Wheatley DJ
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):538-43. PubMed ID: 10962416
[TBL] [Abstract][Full Text] [Related]
26. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
[TBL] [Abstract][Full Text] [Related]
27. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
[TBL] [Abstract][Full Text] [Related]
28. Totally minimized extracorporeal circulation: an important benefit for coronary artery bypass grafting in Jehovah's witnesses.
Vaislic C; Bical O; Farge C; Gaillard D; Ponzio O; Ollivier Y; Abdelmoumen Y; Robine B; Souffrant G; Bouharaoua T
Heart Surg Forum; 2003; 6(5):307-10. PubMed ID: 14721799
[TBL] [Abstract][Full Text] [Related]
29. Prospective randomized comparison of coronary bypass grafting with minimal extracorporeal circulation system (MECC) versus off-pump coronary surgery.
Mazzei V; Nasso G; Salamone G; Castorino F; Tommasini A; Anselmi A
Circulation; 2007 Oct; 116(16):1761-7. PubMed ID: 17875971
[TBL] [Abstract][Full Text] [Related]
30. [The effect of antithrombin iii concentrations during cardiopulmonary surgery].
Sonzogni V; Bellavita P; Carrara B; Cossolini M; Ferri F; Fabretti F; Mamprin F; Pelliccioli I
Minerva Anestesiol; 2000; 66(1-2):17-23. PubMed ID: 10736978
[TBL] [Abstract][Full Text] [Related]
31. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass.
de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C
Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987
[TBL] [Abstract][Full Text] [Related]
32. The value of heparin concentration monitoring in off-pump coronary bypass surgery.
Baykut D; Weichelt K; Wehrle J; Zerkowski HR; Bernet F
Eur J Med Res; 2003 Apr; 8(4):161-4. PubMed ID: 12765862
[TBL] [Abstract][Full Text] [Related]
33. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
[TBL] [Abstract][Full Text] [Related]
34. Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits.
Tanaka H; Oshiyama T; Narisawa T; Mori T; Masuda M; Kishi D; Kitou T; Miyazima S
J Artif Organs; 2003; 6(4):245-52. PubMed ID: 14691666
[TBL] [Abstract][Full Text] [Related]
35. [Inflammatory and fibrinolytic activation after coronary artery bypass with extracorporeal circulation].
Gaudino M; Nasso G; Zamparelli R; Andreotti F; Burzotta F; Iacoviello L; Santarelli F; Lapenna E; Bruno P; Di Pietrantonio F; Schiavello R; Maseri A; Possati G
Ital Heart J Suppl; 2002 Jun; 3(6):646-51. PubMed ID: 12116815
[TBL] [Abstract][Full Text] [Related]
36. Adenosine induces histamine release from human bronchoalveolar lavage mast cells.
Forsythe P; McGarvey LP; Heaney LG; MacMahon J; Ennis M
Clin Sci (Lond); 1999 Apr; 96(4):349-55. PubMed ID: 10087241
[TBL] [Abstract][Full Text] [Related]
37. Effects of preservative-free heparin on plasma histamine concentration and on hemodynamics in patients undergoing aortocoronary bypass surgery.
Adt M; Reimann HJ; Schmucker P; Kuppe H; Weinhold C
J Cardiovasc Surg (Torino); 1989; 30(2):250-6. PubMed ID: 2785115
[TBL] [Abstract][Full Text] [Related]
38. Comparison of methodologies to measure human lung histamine.
Erger RA; Casale TB
J Immunol Methods; 1992 Jul; 152(1):115-21. PubMed ID: 1640106
[TBL] [Abstract][Full Text] [Related]
39. Myocardial preservation, redox potential maintenance and oxidant injury by heparin-coated Carmeda circuit.
Rao PS; Palazzo RS; Harlow GL; Bocchieri KA; Metz HN; Wilson DW; Rao SK; Graver LM
Ann N Y Acad Sci; 1996 Sep; 793():511-3. PubMed ID: 8906202
[No Abstract] [Full Text] [Related]
40. [Heparin and extracorporeal circulation].
THIES HA
Thromb Diath Haemorrh; 1961; 5(Suppl)():99-130. PubMed ID: 13920693
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
